$Importance of non‐cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction$

Importance of non‐cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction

Aims Atrial fibrillation (AF) and heart failure (HF) with preserved ejection fraction (HFpEF) are interlinked and frequently coexisting conditions. To date, patients with AF and HFpEF have limited evidence guiding their management. This study aimed to investigate the predictors of adverse outcomes a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	ESC Heart Failure 2025-02, Vol.12 (1), p.389-400
Hauptverfasser:	Hamatani, Yasuhiro, Iguchi, Moritake, Kato, Takao, Inuzuka, Yasutaka, Tamaki, Yodo, Ozasa, Neiko, Kawaji, Tetsuma, Esato, Masahiro, Tsuji, Hikari, Wada, Hiromichi, Hasegawa, Koji, Abe, Mitsuru, Kimura, Takeshi, Ono, Koh, Akao, Masaharu
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Anemia Atrial fibrillation Atrial Fibrillation - complications Atrial Fibrillation - epidemiology Atrial Fibrillation - physiopathology Body mass index Cardiac arrhythmia Cardiovascular disease Chronic kidney failure Chronic obstructive pulmonary disease comorbidities Comorbidity Coronary heart disease Coronary vessels Diabetes Ejection fraction Enrollments Ethics Female Follow-Up Studies Heart Heart failure Heart Failure - complications Heart Failure - epidemiology Heart Failure - physiopathology Hospitalization Hospitals Humans Hypertension Japan - epidemiology Kidney diseases Lung diseases Male Medical prognosis Original Patients Peptides Physicians preserved ejection fraction Prognosis Prospective Studies Registries Risk Factors Stroke Volume - physiology Survival Rate - trends Vein & artery diseases Ventricular Function, Left - physiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!